This clinical trial showed that celecoxib use resulted in fewer small intestinal injuries compared with a PPI plus nonselective NSAID although it is unclear whether selective COX-2 inhibitors truly prevent NSAID-associated enteropathy. Here, PTGS2 is linked to Abnormal intestine morphology.